RSCM
KRTX

Rock Springs Capital Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Rock Springs Capital Management’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-515,024
Closed -$163M – 117
2023
Q4 		$163M Buy
515,024
+9,591
+2% +$1.86M 4.01% 3
2023
Q3 		$85.5M Buy
505,433
+11,906
+2% +$2.24M 2.29% 11
2023
Q2 		$107M Hold
493,527
– – 2.55% 11
2023
Q1 		$89.6M Buy
493,527
+79,765
+19% +$15.3M 2.14% 13
2022
Q4 		$81.3M Hold
413,762
– – 1.96% 16
2022
Q3 		$93.1M Sell
413,762
-28,131
-6% -$5.69M 2.4% 10
2022
Q2 		$55.9M Buy
441,893
+9,350
+2% +$1.07M 1.63% 19
2022
Q1 		$54.8M Buy
432,543
+5,700
+1% +$642K 1.38% 25
2021
Q4 		$55.9M Buy
426,843
+34,926
+9% +$4.51M 1.29% 26
2021
Q3 		$47.9M Buy
391,917
+5,299
+1% +$612K 1.01% 32
2021
Q2 		$44.1M Buy
386,618
+17,854
+5% +$2.09M 0.87% 35
2021
Q1 		$44.3M Buy
368,764
+124,814
+51% +$14.1M 0.97% 33
2020
Q4 		$24.8M Sell
243,950
-156
-0.1% -$14.5K 0.53% 66
2020
Q3 		$18.9M Buy
244,106
+40,794
+20% +$3.48M 0.48% 69
2020
Q2 		$22.7M Buy
203,312
+23,312
+13% +$2.03M 0.62% 56
2020
Q1 		$13M Hold
180,000
– – 0.54% 62
2019
Q4 		$13.6M Sell
180,000
-180,400
-50% -$7.9M 0.43% 77
2019
Q3 		$5.88M Sell
360,400
-53,100
-13% -$1.03M 0.23% 97
2019
Q2 		$8.28M Buy
+413,500
New +$8.28M 0.3% 87

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Rock Springs Capital Management's KRTX Position: Q1 2024 in Review

Rock Springs Capital Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 515,024 shares — an estimated $163M sold.

Rock Springs Capital Management first reported a position in KRTX in Q2 2019 and held it in 19 quarters. The position peaked at $163M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Rock Springs Capital Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Rock Springs Capital Management sold 515,024 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $163M.
  • Rock Springs Capital Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2019 and held it in 19 quarters.
  • Rock Springs Capital Management's Karuna Therapeutics, Inc. Common Stock position peaked at $163M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Rock Springs Capital Management's 13F filing for Q1 2024, filed 15 May 2024.